BEDAIR Trademark

Trademark Overview

On Tuesday, September 18, 2012, a trademark application was filed for BEDAIR with the United States Patent and Trademark Office. The USPTO has given the BEDAIR trademark a serial number of 85731527. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 30, 2016. This trademark is owned by Glaxo Group Limited. The BEDAIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
bedair

General Information

Serial Number85731527
Word MarkBEDAIR
Filing DateTuesday, September 18, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 30, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Pseudo MarkBED AIR

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 21, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, May 31, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 30, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 16, 2015EXTENSION 5 GRANTED
Tuesday, September 8, 2015EXTENSION 5 FILED
Tuesday, September 8, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 6, 2015EXTENSION 4 GRANTED
Tuesday, March 31, 2015EXTENSION 4 FILED
Tuesday, March 31, 2015TEAS EXTENSION RECEIVED
Saturday, October 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 3, 2014EXTENSION 3 GRANTED
Wednesday, October 1, 2014EXTENSION 3 FILED
Wednesday, October 1, 2014TEAS EXTENSION RECEIVED
Thursday, May 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 30, 2014EXTENSION 2 GRANTED
Wednesday, April 9, 2014EXTENSION 2 FILED
Tuesday, April 29, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 9, 2014TEAS EXTENSION RECEIVED
Friday, October 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2013EXTENSION 1 GRANTED
Wednesday, October 2, 2013EXTENSION 1 FILED
Wednesday, October 2, 2013TEAS EXTENSION RECEIVED
Tuesday, April 23, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 22, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 15, 2013ASSIGNED TO EXAMINER
Saturday, September 22, 2012NOTICE OF PSEUDO MARK MAILED
Friday, September 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 21, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

bedair pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological